Large Iranian Study Proves The Potential Of Polypill Concept

Data presented in The Lancet medical journal suggests a polypill fixed-dose combination of aspirin, atorvastatin and hydrochlorothiazide with either enalapril or valsartan could reduce the risk of cardiovascular events significantly. 

Iran_Map
Research conducted in the Golestan province of Iran supports the use of a polypill to reduce cardiovascular risk • Source: Shutterstock

More from Value Added Medicines

More from Products